Oncology Nursing News®

Tune in to our upcoming broadcast to learn more about advances in the treatment of tenosynovial giant cell tumor. Register today!

Immuno-Oncology

Immunotherapy-Related Myocarditis

Immunotherapy-Related Myocarditis

BY JAVID J. MOSLEHI, MD

Eliminating Gender-Based Barriers to Immunotherapy

Eliminating Gender-Based Barriers to Immunotherapy

BY KATIE KOSKO

ONN's Top 5 Stories: March 2019

ONN's Top 5 Stories: March 2019

BY JESSICA SKARZYNSKI

It Takes a Team: Treating Adverse Events

It Takes a Team: Treating Adverse Events

BY MATTHEW A. GUBENS, MD

Predicting Immunotherapy Response in Bladder Cancer

Predicting Immunotherapy Response in Bladder Cancer

BY ROBERT DREICER, MD

Risks Versus Benefits in Combining Immunotherapies

Risks Versus Benefits in Combining Immunotherapies

BY RYAN J. SULLIVAN, MD

Immune-Related Adverse Events: What to Know

Immune-Related Adverse Events: What to Know

BY JARUSHKA NAIDOO, MBBCH

Immunotherapy Side Effects: What Nurses Should Look Out For

Immunotherapy Side Effects: What Nurses Should Look Out For

BY BRIELLE BENYON

It's 'Just the Beginning' of Exciting Brain Cancer News

It's 'Just the Beginning' of Exciting Brain Cancer News

BY BRIELLE BENYON

FDA Grants Priority Review to Frontline Pembro to Treat Recurrent, Metastatic HNSCC

FDA Grants Priority Review to Frontline Pembro to Treat Recurrent, Metastatic HNSCC

BY KRISTIE L. KAHL

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.